| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1049366578 |
| P356 | DOI | 10.1038/SJ.GT.3302799 |
| P698 | PubMed publication ID | 16708076 |
| P5875 | ResearchGate publication ID | 7073754 |
| P2093 | author name string | Li H | |
| Zhang L | |||
| Li M | |||
| Chen W | |||
| Hu H | |||
| Jia Y | |||
| Feng P | |||
| Lv M | |||
| P2860 | cites work | TAK-220, a novel small-molecule CCR5 antagonist, has favorable anti-human immunodeficiency virus interactions with other antiretrovirals in vitro | Q24530591 |
| Small-molecule antagonists of CCR5 and CXCR4: a promising new class of anti-HIV-1 drugs | Q28274207 | ||
| Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. | Q31059623 | ||
| Magnetic resonance imaging of PLP-induced experimental allergic encephalomyelitis in Lewis rats. | Q31920348 | ||
| Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia | Q33338309 | ||
| Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry. | Q34975941 | ||
| Gene therapy in autoimmune, demyelinating disease of the central nervous system | Q35122159 | ||
| The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system | Q35176521 | ||
| Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice | Q36355148 | ||
| Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways | Q38339762 | ||
| Construction and expression of novel immunotoxin cpIL-4(13D)-PE38KDEL with increased activity. | Q40460456 | ||
| Gene therapy in a murine model for clinical application to multiple sclerosis | Q40584088 | ||
| An anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin avoids inhibition by pre-existing antibodies in human blood | Q41269463 | ||
| Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma | Q41886208 | ||
| Flow cytometric determination of cytokine production and proliferation in hepatitis B core antigen specific murine CD4 cells: lack of correlation between number of cytokine producing cells and cytokine levels in supernatant | Q43782799 | ||
| Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication | Q43798894 | ||
| Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis | Q43873668 | ||
| A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP. | Q45874752 | ||
| The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance | Q46514907 | ||
| Protective DNA vaccination against experimental autoimmune encephalomyelitis is associated with induction of IFNbeta | Q47953576 | ||
| CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. | Q50779652 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression | Q73056551 | ||
| Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling | Q73589598 | ||
| Normal T-helper 1/T-helper 2 balance in peripheral blood of coeliac disease patients | Q74601278 | ||
| Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis | Q77359980 | ||
| Recent progress on tumor missile therapy and tumor vascular targeting therapy as a new approach | Q80473309 | ||
| CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection | Q81019811 | ||
| P433 | issue | 18 | |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| P304 | page(s) | 1351-1359 | |
| P577 | publication date | 2006-05-18 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTES. | |
| P478 | volume | 13 |
| Q37296302 | A novel recombinant immunotoxin with the smallest ribosome-inactivating protein Luffin P1: T-cell cytotoxicity and prolongation of allograft survival. |
| Q36690605 | Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL |
| Q37090589 | An anti-PSMA bivalent immunotoxin exhibits specificity and efficacy for prostate cancer imaging and therapy |
| Q36980670 | CCR6 as a possible therapeutic target in psoriasis |
| Q38040509 | Chemokine-based immunotherapy: delivery systems and combination therapies. |
| Q38056128 | Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases. |
| Q34899535 | Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum). |
| Q37760665 | The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease |
Search more.